newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Allo-Evasion™ 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic immunosuppressionCompelling preclinical data demonstrate rapid reversal